QA – Page 35 – Pharma.Tips

Dedicated vs Shared Facility Decision Criteria for High-Risk Products

Evaluating Facility Structures for High-Risk Pharmaceutical Products In pharmaceutical manufacturing, the choice between dedicated and shared facilities for high-risk products is a pivotal decision that impacts contamination control, compliance, and…

How to Investigate Cleaning and Cross-Contamination Deviations in Pharma

Steps for Investigating Deviations Related to Cleaning and Cross-Contamination in Pharmaceutical Manufacturing In pharmaceutical manufacturing, deviations related to cleaning and cross-contamination can lead to significant quality risks and regulatory scrutiny.…

How to Assess Cross-Contamination Risk in Shared GMP Facilities

Evaluating Cross-Contamination Risks in GMP Shared Facilities Cross-contamination in shared Good Manufacturing Practice (GMP) facilities poses a significant threat to product quality and patient safety. With the rise of multi-product…

Cleaning Deviation Lessons Learned for Inspection-Ready Manufacturing

Understanding and Resolving Cleaning Deviations in Pharmaceutical Manufacturing Cleaning deviations pose significant challenges in pharmaceutical manufacturing, leading to risks of contamination that can compromise product quality and regulatory compliance. This…

Shared Facility Risk Management for Multi-Product Pharma Sites

Effective Risk Management Strategies for Shared Pharmaceutical Facilities In multi-product pharmaceutical manufacturing environments, shared facility risk management is not merely a regulatory requirement but a critical operational necessity. This article…

Cleaning CAPA Governance for Senior Management Review

Establishing Effective Governance for Cleaning Deviations and CAPA Review in Pharma In pharmaceutical manufacturing, maintaining the integrity of cleaning processes is crucial to ensuring product quality and compliance with regulatory…

Campaign Manufacturing Lessons from GMP Inspection Findings

Addressing Challenges in Campaign Manufacturing: Insights from GMP Inspection Findings In the realm of pharmaceutical manufacturing, especially in campaign manufacturing processes, compliance with Good Manufacturing Practices (GMP) is non-negotiable. However,…

Cleaning Deviation Escalation Matrix for QA and Manufacturing Teams

A Comprehensive Approach to Managing Cleaning Deviations in QA and Manufacturing Cleaning deviations can have significant ramifications in pharmaceutical manufacturing, potentially leading to contamination issues and compliance failures. This article…

How to Prepare a Campaign Manufacturing Risk Justification Report

Successful Approach to Drafting a Campaign Manufacturing Risk Justification Report In regulated pharmaceutical environments, ensuring compliance and minimizing risks are paramount. One area that often presents challenges is preparation for…

How to Conduct Retrospective Review After Multiple Cleaning Deviations

Conducting Comprehensive Retrospective Reviews Following Cleaning Deviations Cleaning deviations can have far-reaching implications in pharmaceutical manufacturing, from product contamination to regulatory non-compliance. Understanding how to effectively conduct retrospective reviews following…

Campaign Manufacturing Controls for Equipment Assembly and Disassembly

Addressing Equipment Assembly and Disassembly Challenges in Campaign Manufacturing In the realm of pharmaceutical manufacturing, the practice of campaign manufacturing is essential for optimizing production efficiency and minimizing downtime. However,…

Cleaning CAPA for Equipment Cleaning Logbook Errors

Addressing Equipment Cleaning Logbook Errors in Pharmaceutical Manufacturing In the pharmaceutical manufacturing sector, maintaining compliance with cleaning protocols is crucial for ensuring product integrity and patient safety. However, errors in…